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Many facets of phenylketonuria have been studied 
since the discovery of the disease in 193^-« 
among these is the mental retardation associated with
Since 1953* treatment of this 
metabolic disease with diet therapy has become increas­
ingly successful in alleviation of the mental retardation. 
However, at the present time very few reports are 
available on the influence of a phenylalanine-restrieted 




Statement of the Problem
It was the purpose of this study:
1. To compare the mean height of male and female 
heterozygotes (parents of phenylketonurlc patients) with 
the mean of the normal male and female adult population.
2. To determine if treated phenylketonurlc 
children differed In stature from the norms established 
in the general population.
3. To determine if there was a significant 
difference between stature of treated phenylketonurlc 
patients with "good" control (defined as serum phenylala­
nine levels equal to or less than 4 milligrams per cent) 
versus those with "poor" control, when age of beginning 
treatment was considered.
4. To determine the phenylalanine, protein, and 
caloric intake of phenylketonurlc patients with good 
control (defined as serum phenylalanine levels equal to 
or less than 6 milligrams per cent) and compare this Intake 




Importance of the Study
Those treating the disease have observed that the 
children were of smaller stature than normal children and
smaller than untreated phenylketonuria children.
Searching the literature for growth studies on the phenyl-
^ There have beenketonuric revealed only one report.
some general references suggesting that stature is 
25, 26, 79 yet others have made statements that 
treatment allowed for normal physical and mental 
growth.
and untreated phenylketonuria tends to be smaller than 
average so that "it appears the low phenylalanine diet 
may have little effect on the usual pattern of physical
smaller.
15, 26 Centerwall stated that both the treated
n 25growth.
If the phenylketonuria children were found to be 
of significantly smaller stature than the normal, par­
ticularly if parents compared well with the norms, a
basis would be laid for further research. On the other
hand, if the study showed that the treated children were 
of normal size, concerns related to adequacy of the 
casein hydrolysate to support growth would be relieved.
II. LIMITATIONS OP THE STUDY
Since phenylketonuria is a relatively rare disease 
the sample available for this study was small. Another 
limiting factor was the lack of pre-prepared protocol on 
what, how and when to collect growth and nutritional data.
3
There were inherent inaccuracies in the nutritional
data brought about by the human element as well as a lack 
of nutritional data in some Instances because the parents 
did not keep a three day diet record as requested before 
each serum phenylalanine determination. Complete phenylala­
nine analyses were lacking and those available had been 
based on few samples and old techniques so that in calcu­
lation of the phenylalanine content of the diet, phenylala­
nine as five per cent of total protein was used until some 
time in 1965.
CHAPTER II
REVIEW OP THE LITERATURE
Research on phenylketonuria has intensified during
the past few years, and much has been published in regard 
to this metabolic disease. Only a brief summary of
related research will be presented.
Many growth studies have been reported, particu­
larly during the first thirty to forty years of this 
century. Literature on growth will be cited only as it
has a bearing on standards used for comparing the growth
of the children and as it relates to conditions which
affect growth In general.
I. LITERATURE ON PHENYLKETONURIA
History, Incidence and Etiology
In the spring of 1934 a young mother brought her 
two children to Dr. Asbjorn Polling, a Norwegian 
physician and biochemist, for an examination. They were 
both mentally retarded and had a peculiar odor. When 
Dr. Polling added ferric chloride to their ur^ne, a green 
color appeared which he identified as being caused by 
phenylpyruvic acid. He hypothesized that the disease 
"represented a disturbance in the metabolism of the amino 
acid phenylalanine . . . and that this same abnormality 
might be causing the retardation in these two children 
and perhaps in other mental defectives. h23 In five
4
5
months* time he had identified eight other cases and had 
ready for publication a scholarly report on a new meta­
bolic disease which he called "imbecillitas phenyl- 
„22, 23pyruvica.
It is the opinion of Guthrie and Hsia that the
condition arises once in every 10,000 births in the 
40, 43United States, however, an incidence greater than 
this has been reported in some screening programs.66, 8l
The disease occurs equally in both sexes and is 
found in most races, but is more common in the people of
Northern European and Japanese origin. It is rarely
34, 67found among Negroes and Jews.
Phenylketonuria is a metabolic disease of genetic 
origin. Jervis has shown that the disease is trans­
mitted by a single autosomal recessive gene 
parents are normal because the recessive gene cannot 
gain expression unless It pairs up with another similar 
gene to form the homozygote recessive state. In the 
parents, the normal gene suppresses the one recessive 
gene for phenylketonuria and this condition is described 
as heterozygote. When two parents mate who both have a 
recessive gene for phenylketonuria, conditions are such 




The genetic status of children born from 
marriage of two heterozygote parents shows a 
Mendelian distribution: 1 entirely normal, 2 
heterozygote carriers (clinically normal), 1 
phenylketonuric. It should be emphasized, how­
ever, that this 1:2:1 ratio is statistical and 
that in these families each birth Involves a 1 
in 4 chance that the child will have phenyl- 
ketonuria.^9
The recessive trait is carried by about one In
69, 78fifty to seventy persons in the general population
Clinical Findings in the Untreated
Most infants with phenylketonuria are brought 
to medical attention because of delayed development
in one or more areas. The mothers notice the children
do not sit, stand, walk, or talk at the time normally 
expected.
Mental manifestations. The most striking clinical
feature of the untreated phenylketonuric is mental 
retardation, evident at four to six months of age.1?,43,94 
The large majority of the patients are low grade
Twenty-five or so atypical phenyl- 




Body size, height and weight. References In the
literature relative to size of phenylketonurics either
before or after treatment are rare. One of the first
r»17reports stated Mthe patients are usually well built. 
^5 Cheek,^
were smaller than the average normal child. Jervis
79and Paine noted the childrenCenterwall,
found these patients somewhat smaller than normal
individuals, but when compared with the average defec-
72tive individual, they might appear larger and taller. 
Obesity is a characteristic of the infant with phenyl­
ketonuria and this sometimes leads to a mistaken diag-
60nosis of hypothyroidism.
Neurological abnormalities. Abnormal electro­
encephalograms and other neurological manifestations 
such as convulsions, epileptic seizures, irritability, 
tremors of the hands. Increase In reflexes, temper tan­
trums and hand posturing may occur with varying degrees
43, 67, 78, 93of severity.
Extraneural manifestations. Eczema has been
89 80vomiting in early life is common.reported frequently.
Phenylketonurics are often lighter in color than their 
parents or siblings.^3* 67 
hair Instead of black.^
Japanese patients have brown 
A peculiar musty, mousey odor
is noticed in the urine and sweat and was one of the
first characteristic symptoms noted.
94There is delayed dentition and enamel hypoplasia
8
with wide spacing of the upper incisors in some patients.
Feinberg and Fisch described the presence of calcified
spicules projecting into the epiphyseal area of the long 
37bones.
Biochemistry
Normal phenylalanine metabolism. Phenylalanine is
an essential amino acid in that the benzene ring cannot be 
synthesized in the body. In normal individuals, ingested 
phenylalanine Is used for protein synthesis and the remainder 
(the greatest part) is hydroxylated to tyrosine by the 
action of liver phenylalanine hydroxylase. This Is an 
irreversible reactionj two enzymes, triphosphopyridine 
nucleotide (TPNH), molecular oxygen, ferrous ion, and a 
pteridine like cofactor are required. The metabolic end 
products of tyrosine are thyroxine, epinephrine (adrena­
line), fumaric acid, acetoacetic acid and melanin. Some 
transamination of phenylalanine to phenylpyruvic acid and 
thus to phenyllactic acid takes place, but these reactions 
are reversible and usually end with further catabolism 
through phenylalanine. Traces of phenylpyruvic acid may 
be decarboxylated to phenylacetlc acid. Tyrosine exerts 
a sparing action on phenylalanine to the extent of about 
one-half the dally requirement for growth and three-fourths 
of the requirement for nitrogen equilibrium, since most 
of the functions of phenylalanine are performed subsequent 
to its conversion to tyrosine.70, 87, 100
9
Two enzymes are involved in the phenylalanine 
hydroxylase system, which catalyzes the oxidation of 
phenylalanine to tyrosine. Enzyme I is a labile enzyme 
which has been purified from rat liver and requires DPNH; 
enzyme II is a stable enzyme and requires oxygen, TPNH 
and tetrahydropteridines. This second enzyme is not 
involved in the hydroxylation reaction, but merely 
catalyzes a reaction which keeps the coenzyme in an 
active form so that the hydroxylation can take place.^ 
In Figure I the usual pathways for phenylalanine 
and tyrosine metabolism are outlined.
Jervis demonstrated that the inability of the 
phenylketonuric to metabolize phenylalanine was due to
a defective oxidizing system for converting phenylalanine 
to tyrosine.^ Later he showed that phenylalanine
hydroxylase activity Is not present in the liver of
51patients with phenylketonuria, 
active phenylalanine. It was found that the phenylketo-
By the use of radio-
nuric could oxidize phenylalanine to tyrosine about five
16, 98per cent as well as normal Individuals. Armstrong
states that ten per cent of the phenylalanine is oxidized
to tyrosine.
■34caused by a deficiency of Enzyme I.
hereditary enzyme defect, Hsia states:
All we can say is that the enzyme . . . does 
not appear to be working properly (the enzyme has 
not been crystallized, and there is no physical 
means of showing whether it is present or absent).
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FIGURE 1
METABOLISM OF PHENYLALANINE, TYROSINE, AND TRYPTOPHAN SHOWING 
BLOCKS THAT OCCUR IN PHENYLKETONURIA
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This can occur because the enzyme molecule is com­
pletely absent and hence is unable to do its work. 
More likely, the protein molecule is present but 
there is a genetically determined mutation at the 
reactive site. It Is probable that, as in the 
abnormal hemoglobins, there has been an amino acid 
substitution so that the enzyme-substrate reaction 
cannot take place properly, and one is given the 
impression that we are dealing with an inactive 
enzyme. Finally, it Is possible that the enzyme 
could be both present and structurally normal but 
unable to function properly In the environment 
because of alterations In the host or within the 
cells. A deficiency of cofactors or the presence 
of inhibitors could produce such an effect.^3
In the absence of phenylalanine hydroxylase 
activity, a group of minor pathways of phenylalanine metab­
olism, little used in normal individuals, become promi­
nent. Transamination of phenylalanine yields phenyl- 
pyruvic acid (which forms the green color in the presence 
of ferric chloride). Accumulation of this product leads 
to formation and excretion of phenyllactic acid, ortho- 
hydroxyphenylacetic acid, and phenylacetic acid (respon­
sible for the odor associated with the disease, the 
latter appearing In the urine as phenylacetylglutamine). 
Phenylalanine and phenylpyruvic acid (this usually 
predominates) are also excreted In the urine. A normal 
excretory product, metahydroxyphenylacetic acid, is 
absent or greatly diminished in quantity.
There are increased amounts of indolelactic, indo- 
leacetic and indolepyruvic acids In the urine Indicating 
that a disturbance of tryptophan metabolism is associated 
with phenylketonuria. The serum level of serotonin, five- 
hydroxy-lndoleacetlc acid and other hydroxylated deriva-
13, 21, 34, 70, 94, 100
12
tlves of tryptophan are lower In the untreated phenylketo­
nuria, showing a close inter-relationship in the hydrox-
68, 70, 94, 101 It hasylation of aromatic amino acids, 
been found that the same enzyme which hydroxylates phenyl­
alanine also hydroxylates tryptophan to five-hydroxy-
Fhenylala-16, 70tryptophan, the precursor of serotonin, 
nine metabolites have an Inhibitory effect on five-
34hydroxytryptophan decarboxylase.
The decreased pigmentation in phenylketonuria 
results from the competitive Inhibition of phenylalanine 
on the tyrosinase system which catalyzes the first step 
and accelerates the second step in the metabolism of
If the intake of tyrosine is 
increased or the intake of phenylalanine lowered (as in 
treated patients) the hair and skin become darker.^* ^7* 94 
There are no detectable abnormalities in the amino
tyrosine to melanin.
acid composition of proteins of various tissues, or serum
15, 34, 67proteins, or of hemoglobin In the phenylketonuria.
The phenylalanine level In the cerebrospinal fluid is one- 
fourth of that In the plasma.^ There is an altered 
pattern of plasma amino acids; the alpha amino nitrogen 
of the phenylalanine found in phenylketonuria is about / 
half of the normal total alpha amino nitrogen of plasma, 
yet the total alpha amino nitrogen in the plasma Is not 
substantially higher than normal. The high phenylalanine 
content evidently causes a depression of the concentration 




70, 89, 94normal level and histidine at an increased level.
Figure I, page 10, shows the main alterations of 




Since the clinical symptoms of phenylketonuria 
result from the accumulation of phenylalanine and its 
metabolites in the body, treatment is aimed at reducing 
these biochemical compounds. This is accomplished by the 
use of a phenylalanine-restrieted diet.
Bickel and coworkers (1952) were the first to 
devise a low phenylalanine diet which they administered 
to a phenylketonuria. Blood phenylalanine was reduced 
and phenylpyruvic acid in the urine disappeared.^
Early diagnosis and dietary treatment are of
utmost importance in preventing the associated mental
In older children, increase in intelli-58, 61changes.
gence cannot be expected, but clinical symptoms 
18, 45, 67improve.
The major source of nutrients In the phenylalanine- 
restricted diet is supplied by the use of a specially 
processed protein hydrolysate, low in phenylalanine.
This amino acid is purposely low so that the phenylala­
nine requirements may be adjusted to meet the individual^ 
requirements for growth. This Is accomplished by the 
judicious addition of a wide variety of natural foods.
14
thus allowing the phenylketonurlc*s diet to be as near
14, 61, 67, 99normal as possible.
The diet and Its nutrients. The optimal daily-
intake of phenylalanine for the phenylketonurlc infant
has been estimated to be forty to twenty milligrams per
pound each day^ with a gradual decrease of requirements
on a weight basis with Increasing age in each child.1
The phenylalanine requirement for the normal infant is
qp^ Others have
, 2, 24
forty-one milligrams per pound per day. 
reported considerable variation in the amount of phenyl­
alanine needed by phenylketonurics during the first year
of life, both from infant to infant, and at different
56, 100times in the same infant. Two and a half to
seven milligrams per pound per day has been set as the 
possible daily needs of a fifteen year old phenylketo-
pnuric boy.
A Phenylalanine requirements vary but rise to a 
maximum when body protein is being formed at the 
highest rate. This parallels rapid growth which
occurs during the first year of life. The time 
and degree of this peak varies from infant to 
infant. Older children usually have a relatively 
lower requirement, but their tolerances are variable 
also . . . All low-phenylalanine diets must be 
tailored and altered according to the individual 
child*s tolerances and requirements.99
The protein need of phenylketonurics may be higher 
than for the normal child since the protein is in the form 
of a casein hydrolysate. At the present time one and 
three fourths to two grams of protein per pound is 
recommended for the infant up to three months of age and
15
one and a half grams for the infant from four months to
89 These recommendations are higher than thosea year.
for the normal baby.
Caloric intakes of phenylketonuric children on the
low phenylalanine diet have been higher than the National
47, 84, 100Research Council recommends. Centerwall
suggested sixty to sixty-five calories per pound per day
ohfor the infant with phenylketonuria.
Treatment and growth. Very little appears in the
literature with the exception of general statements that 
a phenylalanine level should be maintained which will 
allow for satisfactory growth and that if this level is 
too low, growth responses will be inadequate. Centerwall
stated "the children generally had somewhat slow growth
n25patterns but were well nourished for their heights.
Of the six children who were started on the low phenylala­
nine diet after eight months of age, five maintained a 
growth pattern similar to that of the pre-diet period.
He reported significant drops in percentile levels in the 
babies who were started on treatment before two months of
age. In conclusion he wrote:
Observations on physical growth show that the 
children^ heights tend to be below average, but 
their weights have been in good proportion to 
their heights. In that untreated children with 
phenylketonuria also tend to be smaller than 
average, it appears that the low phenylalanine \ 
diet may have little effect on the usual pattern: 
of physical growth.25 y
16
On the other hand. Cheek stated that the use of the low
/
phenylalanine diet improved both mental and physical 
status,2^
found and placed on the diet grow normally, both physically 
and mentally.
and Bessman says "the majority of the cases
nl5
A German scientist observed significant retardation 
of growth in children suffering from phenylketonuria and 
treated with a low phenylalanine diet, compared with 
untreated phenylketonurics. There was a retardation of 
bone age and a thickening of the metaphyseal plate, which 
he felt was due to changes in amino acid balance.This 
same author reported that growing rats fed with protein 
hydrolysate low in phenylalanine showed definite growth 
inhibition, but with the addition of phenylalanine and 
tyrosine, retardation of growth was prevented. Further 
studies on the rats "revealed definite structural and
"32biochemical changes mostly in the epiphyseal growth area.
That there may be definite changes in bone growth 
has been shown by others. Feinberg and Fisch studied a 
group of thirty-three patients at the University of 
Minnesota Hospitals; five in the younger age group showed 
unusual bone changes in growing long bones. Serum calcium, 
phosphorus and alkaline phosphatase were in the normal 
range and they did not think that diet was related to 
the cause of changes in the long bones.37 However,
Murdock and Holman followed two phenylketonurics from 
infancy and found a direct correlation between diet.
IT
serum alkaline phosphatase, and epiphyseal spiculation. 
’’Both patients exhibited subnormal bone growth, decreased 
weight gain, and lowered serum alkaline phosphatase 
levels, corrected by increasing dietary phenylalanine. 
Hsia states that calcified spicules have been found to 
project into the epiphyseal area of long bones and 
cupping occurs in the metaphyseal plate, along with 




Termination of dietary treatment. Various ages
have been proposed as to time the diet might be 
4, 22, 102 Horner reported termination of 
dietary treatment at four years of age on three children
discontinued.
with phenylketonuria, treated from earliest infancy, and 
found no deterioration of mental development. 42 However,
Koch cites a case which had been treated from sixteen
months to four years of age. At age six and a half the 
child was brought to his clinic when she began to 
experience psychomotor seizures. He states that dis­
continuance of diet therapy may be hazardous and 
recommends caution when considering it. 89 At the present.
both Koch and Bickel continue diet therapy at least
59, 60, 67until adolescence.
18
II. LITERATURE ON GROWTH
Today there is no lack of literature on growth and 
In fact, the "pediatrician and hisits many aspects, 
ancillary colleagues may well be overwhelmed by the quan­
tity of data, charts and grids concerning growth that
"35have appeared in the last 20 years.
Assessment of Growth
Ideally, growth and development are assessed 
through observations and measurements obtained from 
pediatric examinations, health and dietary records, 
x-rays, anthropometric measurements, dental examinations, 
measures and observations on the skin, hair, muscle and
subcutaneous fat, observations of sexual maturation and 
biochemical tests. Practically, the investigator usually
has to settle for those observations and measures which
are directly concerned with his purpose for the research.
Since this study is concerned with anthropometric measure­
ments and dietary records, the discussion will be limited
to these phases.
Anthropometric measurements. There is a minimum
of lengths and circumferences which should be maintained 
In any growth study. Garn has slightly modified those 
which were recommended by the Committee on Nutritional
Anthropometry, Pood and Nutrition Board, National
28Research Council In 1956. In the listing, the
19
measurements are rated from A (absolutely essential) 
through E (desireable but rarely practical In the field). 
This listing follows:^
Birth and 1 month
Length (crown-heel and crown-rump) and weight. 
Head circumference, chest circumference. 
Bicristal diameter.
Pat-folds at triceps, below the scapula and 
on the chest at the mid-axillary line.
During the first year
Lengths (including stem length) and weight. 














Lengths, standing height and weight. 
Circumferences, excepting head after 3 years. 








Prom 7 years on.
A. Lengths, height and weight.
maturation.
Chest, arm and calf circumference. 








Reasonable care should be exercised that these
measures be taken with accurate, readable scales, calipers, 
and tapes. Weight should be taken after the bladder has 
been emptied, clothing should not be a variable factor.^
In order that there may be an accurate comparison 
with established norms, measurements and observations 
should be made at constant intervals. 7 ideally on the
20
subjects birthday or half-birthday or at other pre-
However, this is usually not possible 
and it is reasonable to allow for small tolerances, 
suggests plus or minus 1 day until 3 months> 2 days at
ending with plus or 
Interpolations are not 
the best as velocity of growth varies with age and also
The children in the Brush
determined ages.
Garn
six months, 4 days at one year, etc 
minus 25 days at 7 years of age.^
•»
71with adverse Influences.
Foundation Study were measured within a week of their
91birthday.
As an indicator of growth, height is fairly stable,
whereas weight is influenced by many factors and may
fluctuate greatly. A weight measure can be lost in
disease, malnutrition or dieting, whereas height is not.
It is necessary to know whether weight represents water,
muscle, bone or fat.^^ Simmons states that "as a measure
of growth, stature is superior to weight,




The use of x-rays to determine skeletal 
maturity is a relatively simple and effective tool in 
assessing growth and is reasonably independent of body 
size. ^
biological age.
The Atlas of Greulich and Pyle^^ is the standard 
of reference generally used in the United States for
X-rays.
It is the most widely used method of determining 
54, 62
21
53 An x-ray of the leftthe determination of bone age. 
hand is made and the number of calcified centers and the 
amount of calcification is matched with a standard set of 
films, each representing an average child at a particular 
55 when the nearest matching film has been found, the 
age from this film becomes the ’’bone age" of the child 
whose skeletal maturity is being assessed. Growth time
age.
available to the child is related directly to the degree
11, 53of skeletal maturity exhibited.
One measure or film will give the status of the
child at that time and has some use, but rate of progress
seen through successive films is of more value in evalu-
54ation of growth.
Dietary records. Nutrition is an important factor
for investigation in relationship to the various aspects 
of growth, development, and health of children. Dietary 
records should be both qualitative and quantitative, and 
’’should be made in conjunction with a competent nutri­
tionist, preferably one with research training and field 
experience. H 38
Growth Studies
Ideal patterns of growth for healthy children are 
not known, though many studies provide data for growth on 
selected populations.
The Iowa growth charts used regularly In pedia­
tricians1 offices were based on 13,000 cross sectional
22
height and 11,000 weight observations of Iowa city boys
and girls between 1920 and 1940. The majority came from
49the higher socio-economic group.
The Brush Foundation Study (1931-1942) was longi­
tudinal in nature. The 999 children studied were a
sampling of the Greater Cleveland child population 
selected on the following basis: l) voluntary partici­
pation, 2) agreement to continued participation, and 
3) freedom from gross physical and mental defects. The 
parents were from above average economic and educational 
status, all white, and of North European ancestry. The 
children were measured while dressed in indoor clothing 
with shoes removed. 90 This is the study on which Greulich 
Two other well known longi­
tudinal studies are the Harvard and Berkeley studies.
and Pyle*s Atlas was based.
8,9,96.97
Growth Patterns and Hate of Growth
The growth of normal children is continuous but 
not necessarily uniform from one age to the next; there 
are periods of both rapid and slow growth. In general 
all children grow rapidly the first year, slowly from 
then until the pre-adolescent growth spurt.
At birth and during the first year of life, boys 
are slightly heavier and taller than girls.2+1 Sex
differences tend to be negligible from about three years
90through ten to eleven years.
In stature.^
when girls exceed boys 
From this age until thirteen, the girls
23
are taller, after which the boys catch up and pass. Boys 
mature approximately two years later than girls with the 
pre-adolescent growth spurt coming between the ages of
eleven to fourteen. This growth spurt manifests itself
41, 90 If there isbetween ages nine to twelve in girls, 
an unfavorable environment for growth, there is a lagging
rate of skeletal maturation. Males are more subject to
33, 53, 62this maturation lag than females.
There are two sets of growth factors, one which
determines the ultimate size of the individual and one
which determines the speed at which the individual will
53attain this size. The extra tall girl may be closer
to maturity than the shorter one or she may have a much
greater growth potential.
The growth curves for height and weight have been
derived from averages of the measurements of large
numbers of children at each age. For children under nine
years, this method Is acceptable, but after this age,
comparing an individual child with the average can be
very misleading since the prepubertal growth spurt can
come very early or very late (and yet be very normal for
this Individual) and this spurt Is much more rapid than
9is indicated by the curves of averages.
Reed and Stuart report a wide range of variation 
observed In the growth curves of height and weight in 
their series of 134 children. They found that ’’the rate
24
before 6 years of 
age was associated with, but not specifically predictive 
of, size at maturity and timing of the adolescent growth 
spurt. Individuals with rapid growth before 6 years of
of growth during early childhood, i.e • 9
age tend to have large mature size and early adolescent 
m85growth spurt.
It has been shown that children shift through more 
of the stature range during the early period of life and 
hold their approximate position during the middle period
Thus, self-predictability of stature 
is poorest during infancy and can be predicted somewhat 
more accurately at an age before the pre-adolescent 
spurt.
71, 90of childhood.
In addition to periods of both rapid and slow growth 
naturally occurring in normal children, there are sudden 
spurts, often termed “catch up phase of growth” after an
adverse circumstance such as illness or malnutrition has
41, 83 Cravioto found that when young, mal­
nourished children were placed on a good diet, the rate
been removed.
of growth was very fast at the beginning of the rehabili­
tation period, but slowed later on. The initial rate 
corresponded to the actual size of the child. However, 
growth ceased at the usual chronological age, and the 
child became an undersized adult.^9 This Is in line with 
Mitchell^ findings that “full growth potential must be 
used continuously If full development is to be achieved. «»74
However, Holt states that If the duration of growth
25
arrest has been short, the sudden spurt or "catch up" 
phase may compensate entirely for the growth arrest.
There has been an increase In stature and weight 
in many countries during the past hundred years, thus
the age at which a child attains a given height or
36, 41, 57, 62, 72weight has been reduced. However, this
secular Increase in height and weight seen in the United 
States during the last century may be at an end. 
studied recently show the same growth pattern (length 
and weight) as well cared for infants from the same area
Infants
88thirty years ago.
Factors Which Influence Growth
There are many factors which Influence growth and 
to do a thorough review of all would be quite impossible 
and much beyond the scope of this present research, 
this review will be brief and cover those factors impor­
tant for this study.
Hence,
Genetic Influences. The rate and pattern of growth
and body size an individual attains is determined by
28genetic and environmental factors.
background has been estimated to be as much as eighty per
Bayley found that there was an
increasing correlation between the child's height and that
10of the parent of the same sex as the child grew older. 




cent of all influences.
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Mitchell states that each child inherits genes for 
height and shortness, but that it is the inheritance from 
the taller parent that predominates.
X-rays reveal that genetic control is linked not
only to variation in ossification patterns but also to
28, 53the speed at which these develop.
Studies of the relationship of rate of growth and 
nutrient intake suggest that infants have genetically or 
physiologically predetermined maximums of statural growth 
which they could not exceed no matter how much they
88increased nutrient intake. Thus, it is seen that final 
stature is limited by heredity, but whether or not the 
individual realizes his full potential is determined by
28environmental factors.
Endocrine influences. The anterior pituitary.
thyroid, adrenal cortex and gonads secrete hormones which 
influence the rate and timing of growth. This Influence 
is a very complex one. At the present time very little is 
known about the factors which control the rate of
secretion of the growth hormone, somatotropin, by the 
41, 49pituitary.
Birth weight and subsequent growth. It has been 
suggested that birth weight may be connected with later 
growth. "A striking high proportion of children of the 
smallest birth weight were far below the ‘normal* weight 
in later childhood . , . There were similar but less
27
striking changes in the mean height of these children at 
all ages. n48
Climatic and seasonal Influences. An Interesting
He found Los Angelesstudy was reported by Lloyd-Jones.
Public School children in 1937 to be superior in height
and weight to any other group and concluded that this
superiority must "in part be put down to environmental
n64influence in that area.
Holt states that season affects growth and he found
weight gain to be greater in late summer and fall than
41 However, Prader, 
Tanner and von Harnack report that a minority of children 
regularly grow faster in height in spring and summer. One 
child showed a springtime velocity nearly double the
in winter, spring or early summer.
83autumn rate.
Nutritional influences. The relationship of good
nutrition and physical growth has long been recognized. 
Minimum requirements for many nutrients have been estab­
lished. In the United States today efforts are being
made to establish optimal levels and even maximal levels
12of nutrient intake compatible with health.
As mentioned previously, the growth of infants now 
is about the same as twenty years ago for the same area 
of the United States. This would indicate that with
optimal nutrition, there has been no further increase in
28
growth. The nutrition of these children has allowed them
to obtain their genetic potential but increases past this
28, 86, 88point do not occur.
Arrested growth occurring in conjunction with 
severe nutritional deficiencies has been noted with
increasing frequency in developing countries. However, 
there must also be a class of children in whom nutri­
tional limitations are such that frank clinical symptoms 
are absent, yet who do not reach their full growth poten­
tial because of these limitations.^
The extent to which undernutrition influences the
size of an individual depends upon the age at which it 
occurs, the greatest effect being at the period of maxi­
mum growth, and its duration in relation to the total
33period of growth, 
weight of 56l children with chronic nutritive failure 
with a group of adequately nourished, ethnically compar­
able children from the same geographic region. The under­
nourished children showed a substantial lag in height by 
the third year of age; this lag increased progressively 
in the boys while it remained constant in the girls.
Several examples of nutritional limitation are 
cited by Mitchell. Viennese children after World War I 
were two to three years behind in height and weight.
Growth of children in Stuttgart, Germany, was compared 
and a significant difference was observed between those
Dreizen compared the height and
29
from the low Income families and from upper income families.
In both there was a leveling off or drop in stature after
the two world wars and a period of unemployment In the
A survey of Guam children in 1947 showed
all to be retarded In height, weight, and skeletal 
75maturity.
early 1930's.
Japanese data, where heights and weights of all 
school children had been recorded annually since 1900 
showed a steady increase In stature until 1939. When the 
heights were again recorded after the war (1948), stature 
at every age was less than it had been in 1939. Since 
that time, there has been a steady increase in height 
along with concommltant Increase of animal protein 
consumption. To find whether this increase was due to 
better nutrition, the author studied data from twenty- 
two orphanages. These children were smaller In stature 
than Japanese youth in general. When the nutrients from 
the foods used in the institutions were calculated. It 
was found that animal protein was a serious limitation. 
The Pood and Agriculture Organization protein scores 
varied from sixty-seven to seventy-four in these orphan­
ages. The limiting amino acids were tryptophan, the 
sulphur-containing amino acids, or both in all the 
institutions. These findings seem to "corroborate the 
theory that better nutrition, and particularly more 
adequate protein, are significant with respect to
h75stature.
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A retardation of skeletal age is evident when there
there may also be a consider­
able frequency and variety of anomalies in the bones of
Bone growth depends primarily on 
the proliferation of cartilage cells before calcified 
bone can form. This mechanism is very sensitive to both 
qualitative and quantitative limitations of protein.
Since cartilfiige is protein and the growth 
mechanism is extremely sensitive to a protein 
limitation, it is understandable that physio­
logic growth may slow down or stop when the 
protein supply is limited in quality or quantity 
. . . The first reaction of young bone to growth- 
impeding factors is localized in and around the 
cartilage cells. The number of these cells is 
reduced as new bone production is limited.
Apparently then this mechanism may be affected 
by a mild protein limitation when there are no 
other signs of a deficiency.75
When malnourished children are treated with pro­
tein supplements, epiphyseal calcification progresses 
more slowly than weight.
The Harvard Growth Study included a nutritional 
study by Burke.^
National Research Council Recommended Allowances showed
is chronic malnutrition;
««33the hand skeleton.
A comparison of her findings with the
average values for nutrient intake and especially protein 
to be higher than those recommended.
Enormous differences between individuals of the 
same age and sex are equally obvious in the findings. 
At every age, for both sexes, and for both calories 
and protein, there was at least one child whose 
intake was approximately twice as high as that of 
one or more other children of the same age and 
sex ... It was evident that many children varied 
widely from the average pattern In both level and 
rate of change in Intake from year to year.19
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Rueda-Williamson conducted a longitudinal study of 
sixty-seven infants from two to fifteen months of age; 
his report relates growth and nutrient intake simultan­
eously. These infants were from the same geographic area 
and ethnic groups as those who had participated in the 
Harvard Studies. The infants had high caloric and very 
high protein intakes as compared with the National Research 
Council Recommended Allowances. "The correlation between
length increment and calorie or protein intake was not 
significant. The correlation coefficients between weight 
increments and calorie intake were significant but 
low.”88
Nutritional studies were added to the program of 
the Denver Longitudinal Study in 1946. Beal presents 
data on height of these children to show the variety of 
individual patterns attained. Two boys had a similar 
caloric intake and weight but the second boy had consid­
erably wider fat layers. Two other boys had similar 
caloric intake but were alike in height only. The four 
girls compared varied as much. It was concluded that 
caloric intake alone "cannot be expected to have a high 
positive correlation with weight gain.
The dietary pattern of Indian pre-school children 
was correlated with height and weight. Those receiving 
the most protein showed the greatest increase in weight. 
Heights did not differ significantly.
„12
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Mental deficiency and retarded growth. There are
conflicting opinions regarding the relationship between 
mental deficiency and physical growth. Quoting from 
Kugel and Mohr: "Many are of the opinion that the 
factors which operate to produce mental debility also 
seem to produce a general physical inferiority, others 
emphatically maintain that this relationship is slight 
or even non-existent. »63
Skeletal age has been found to be closely corre­
lated with chronological age and not delayed in the 
mentally retarded. However, if these patients were 
divided into diagnostic categories, those with disorders
of metabolism exhibited the greatest percentage delay in
82bone maturation.
Cravioto proposes that malnutrition in the very 
young individual may produce mental retardation that 
does not repair with dietary restoration. In five 
different communities of Mexico and Guatemala he found
high correlations between deficits in height and weight
29and developmental scores.
A recent cross-sectional survey of physical 
measurements on Caucasian institutionalized mentally 
defective patients showed a positive correlation of 
height and weight with intelligence in both sexes.
The fact that these patients were institutionalized 
might in itself have had a bearing on their height and 
weight. Some are of the opinion that institutionalization
33
tends to lower the Intelligence quotient due to lack of
stimulus in the social situation and this could be a
Also, the diets might not be taken
Perhaps nursing
factor in appetite.
as well due to inability to self-feed, 
does not have as much time and interest to help the
patient with his food as the interested family members do. 
However, research at a Child Development Clinic confirms 
the positive correlation of intelligence and physical 
growth.
The degree of physical impairment is related to 
the severity of mental retardation. Regardless of 
the cause of the disorder, the data presented 
support the conclusion that the degree of mental 
retardation and the degree of physical growth 
deficiency are related, and that the greater the 
mental defect, the more checked will be the physical 
growth . . .
While it is clear from this study and others 
that there is an association between physical 
development and mental development, it is not clear 
whether this is a cause and effect association . . .
The supposition that brain defect can of 
itself produce physical growth retardation, may 
be a reasonable hypothesis.^3
Gulley found that profoundly retarded children, 
with or without motor dysfunction, were shorter and 
lighter for their age than higher functional children. 
On the other hand, it is reported that Servian children 
“who had been seriously undernourished in infancy were
found at schoolage to have normal physical character-
«20istics but subnormal mental capacity.
Summary
Growth is dependent on a great many genetic and
34
environmental factors. Control rests In the continuous
interplay of these forces operating through the endocrine 
and nervous systems. Harmony among these forces results 




The methods of procedure are discussed under three 
general classifications: 1) selection of the subjects 
and data, 2) collecting and recording the data, and 
3) analysis of the data.
I. SELECTION OP THE SUBJECTS AND DATA
Data utilized for this study was secured from the 
medical records of phenylketonuric patients of the Child 
Development Clinic of Children^ Hospital, Los Angeles, 
California. At this clinic the children were seen at
regular intervals on an outpatient basis for evaluation 
of medical and developmental status. Data from forty-eight 
medical records was used for the statistical analyses and 
In some instances this number was further reduced. The 
number of cases and/or measures are listed in each table.
The criteria for selection of the subjects for the 
growth study were: 1) there must be serial measurements 
of patients height, and 2) there must be serial serum 
phenylalanine determinations.
The criteria for selection of the data for the 
nutritional study were: l) the serum phenylalanine level 
must be equal to or less than 6 milligrams per cent.
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2) records of simultaneous serial phenylalanine, protein 
and calorie intakes must be available, and 3) records of 
simultaneous weights must be available.
II. COLLECTING AND RECORDING THE DATA
The following data were collected from the medical 
records: birth date of the child, serial heights and 
weights, bone ages, serial serum phenylalanine levels in 
milligrams per cent, intakes of phenylalanine in milli­
grams per day, protein in grams per day, and calories 
per day, with the date of each measure and/or observa­
tion. Pather*s and mother’s heights were also recorded. 
Age records were to the nearest whole month, inches 
were to the nearest one fourth, ounces were to the nearest 
tenth of a pound. Height and weight measurements before 
2 years of age were made without clothing. After two 
years of age, only the shoes were removed. Standing 
height was used as soon as the child could stand erect.
Intakes of phenylalanine, protein, and calories 
were calculated from three day diet records kept by the 
parents immediately before the blood specimen was 
obtained for determination of serum phenylalanine. Cal­
culations of protein and calories were based on analyses
27listed in Pood Values of Portions Commonly Used. Data
for calculation of nutrient content of the casein hydro- 
sylate (Lofenalac) was based on manufacturer^ analysis. 
Previous to July, 1965, phenylalanine was calculated as
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five per cent of all protein; after this date, phenylalanine 
was determined from the analyses listed in Pood Values of 
Portions Commonly Used2^ and Journal of the American
Dietetic Association,73
III. ANALYSIS OF THE DATA
Parents1 Height
Analysis of parents* height consisted of obtaining 
the mean and comparing this with the mean for the adult 
white American male and female.3
Height of Phenylketonuric Children
Statistical procedures were applied to the following 
hypotheses as Indicated:
Hypothesis I. The mean of the last reported height 
of phenylketonuric children Is less than the mean of the 
expected heights.
The z test for large sample correlated data was 
used to test the significance of difference between means 
of the last recorded height of treated phenylketonuric 
children and normals. The following formula was applied:
MaMlZ *
2
(^mg)+ m2 - 2r1 2
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Where « mean height of normals and Mg = last recorded 
height of phenylketonuria patients.
41Existing norms from the Brush Foundation Study 
were used as a basis for comparison of the growth data 
in this hypothesis. Since the children in this study 
were not measured exactly at ages which correlated with 
those of the normal growth study, it was necessary to 
interpolate the norms to arrive at the age on which the 
measurement used for the analysis was taken.
Hypothesis II. Phenylketonuria children whose
treatment was instituted at or before six months of age
are shorter than those whose treatment was instituted
after six months, when the two groups are made comparable 
(by covariance) in terms of mean height at time treatment 
was started.
Hypothesis III. Phenylketonuria children under 
"good" dietary management are shorter than those under 
"poor'1 control when the two groups are made comparable 
(by covariance) in terms of mean height at time treatment 
was instituted.
Hypothesis IV. Phenylketonuria children whose 
treatment was instituted at or before 6 months of age 
under "good” control and those treated after 6 months of 
age under "poor” control differ in height from those who 
were treated at or before 6 months under "poor” control 
and after 6 months under ’’good” control.
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Hypotheses II, III, and IV were analyzed using the
The covariate was the height atanalysis of covariance.
time treatment started after the data was transformed by
E), where A = actualthe following formula: (A
E
mean of normativeheight, E = estimated height, i.e 
data at same age as case, 
making the heights comparable at beginning of treatment 
through a statistical procedure, so that if there was a 
later difference, this would have significance.
* i
This was simply a means of
In testing Hypotheses II, III, and IV, the groups 
were divided according to control and age. 
described as having ’’good" control were those whose 
serum phenylalanine levels were equal to or less than 
4 milligrams per cent, 75 per cent of the time, 
in the "poor" control group had serum phenylalanine 
levels greater than 4 milligrams per cent greater than 
75 per cent of the time, 
of "good" and "poor" control in the growth section was 
based on a different serum phenylalanine level than the 
criteria for selection of the data used in the nutritional
Patients
Those
It should be noted the criteria
section. It Is the opinion of some investigators that 
very low serum phenylalanine levels cause growth retar­
dation. For this reason, a lower level was chosen for 
this section of the study.
Groups were further divided according to age of
one group was 6 months of agebeginning treatment; I.e • t
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or less at beginning of treatment, the other group was 
over 6 months of age at beginning of treatment, 
four groups were formed with 6 patients in the "young- 
good" group, 6 in the "young-poorM group, 10 in the 
"old-good" group, and 26 in the "old-poor" group, 
method of comparison is illustrated by the following 
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6 months > 6 monthsL
Nutritional Data
For analysis of the nutritional data, the ages of 
the patients were divided into intervals by months and 
nutritional data was obtained (only if the simultaneous 
serum phenylalanine level was equal to or less than 6 
milligrams per cent) for the following groups:
Group 4. 10<12
Group 5. 13<36
Group 6. 37< 72
Group 7. 731108




Means and standard deviations of Intake of phenylalanine, 
protein, and calories were obtained. Protein and calorie 
Intake was compared with the National Research Council 







The results are discussed under two general 
headings: growth data and nutritional data.
I. GROWTH DATA
Parents1 Heights
Since heredity plays such a large part in the 
stature of an individual, the parents* heights were com­
pared with the mean height for the American white male 
and female. There were 36 sets of parents* heights 
available for use in this part of the study. The range 
of the fathers* heights was 61.50 to 78.00 inches with a 
mean of 69.83 inches as compared to 69.68 inches for the 
American white male. The range of the mothers* heights 
was 57.50 to 71.75 Inches, with a mean of 64.49 inches 
as compared to 64.17 inches for the American white 
female. The mean height of parents of phenylketonuria 
children was slightly above the mean height for the 
average white American, though only slightly so.
>
Hypothesis I.
This hypothesis deals with the comparison of the 
heights of the treated phenylketonuria children and normal 
children. The mean height of the research group at time 




children's heights at the same ages was 33.11, a diff­
erence of approximately one half inch. The mean of the 
latest measured height of the research group was 40.96, 
the mean for the normal children's height was 42.36, with 
standard deviations of 8.91 and 8.42, respectively. The 
difference of 1.40 inches would seem to indicate that 
treated phenylketonuric children were shorter than the 
general child population. The z test was applied to 
determine if the difference between the means of the
treated phenylketonuric children and the normals was 
significant. Very significant differences were found. 
A probability of <, .001 indicated that the children in 
this sample could not have been drawn from the normal 
population more than 1 time in 1,000 if only chance
differences were occurring. The conclusion reached was
that treated phenylketonuric children were shorter than
normal children. This difference in stature could be
due to one and/or several unknown factors. The disease 
itself may cause the growth retardation or there may be 
diet related factors, one of which could be an amino acid
imbalance.
Hypothesis II
When the last recorded heights of the phenylketo­
nuric children were analyzed (by analysis of covariance)
thoseconsidering time of beginning of treatment, i.e 
started on treatment 6 months of age versus those
• >
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started on treatment after 6 months, it was found that 
there was no signifleant difference between the two groups
The conclusionin terms of their last measured height, 
was that age treatment was instituted in the phenyl- 
ketonuric children makes no difference in their later
heights.
Hypothesis III
Hypothesis III evaluated the stature increase of 
phenylketonuric children in terms of 'control" as 
defined in the chapter on methodology. Again the research 
hypothesis was rejected as no significant difference was 
found between the last measured heights of those under 
"good” control and those under "poor" control. Thus, the 
state of control of the treated phenylketonuric child 
did not make any difference in growth, when height was 
the parameter used as a measure.
Hypothesis IV
When the group whose treatment was started at or 
before six months of age In "good" control and the group 
whose treatment was started after 6 months of age In 
"poor" control were compared with those whose treatment 
was started at or before six months of age in "poor" 
control and those whose treatment was started over six 
months of age in "good" control, no significant difference 
was found in terms of their last measured height. Again
45
It was shown that control and/or time of beginning of 
treatment had no effect on later height of phenylketonurlc
children.
Skeletal Age
There were 40 children for whom one or more skeletal
Of this number, 22 had a normal boneages were available, 
age, 9 had a retarded bone age, and 9 had reports of both
normal and retarded bone age. In the latter group, four 
were retarded at beginning of treatment and later normal, 
five were normal at beginning of treatment and were later 
retarded. Three of those who were normal at beginning of 
treatment and later retarded had returned to normal on a
subsequent x-ray. In one child treatment began at 10 
months of age but at 3 years 5 months there was a retarded 
bone age, however, this returned to normal three months 
later. Another child whose treatment began at 8 months 
had a retarded bone age at 3 years 9 months; this also 
returned to normal when he was 4 years 4 months old.
An Interesting observation was that those having 
both normal and retarded bone age ratings fell within 
the group who were 24 months or younger at time treatment 
was instituted. This change in skeletal age probably 
reflects a growth pattern normal for those children.










4Retarded at beginning of treatment 
Normal at beginning of treatment 5*
♦Of this group, 3 had returned to normal on a subsequent 
-measure.
II. NUTRITIONAL DATA
Table II gives the means for serum phenylalanine 
level, dietary phenylalanlne, protein, and caloric intakes 
for each of the age Intervals. In the first Interval, the 
mean age was 2.3 months with a standard deviation of 0.65 
indicating that there were no measures for children under 
approximately six weeks of age. This material Is 
graphically presented in Figures 2, 3, and 4.
Mean serum phenylalanine levels ranged from 1.4 to 
2.8 milligrams per cent and Indicated that the children 
were in good control. However, this was inherent In the 
data selected since the criteria for use of the measure
was that serum phenylalanine level be equal to or less
TABLE 11
MEAN SERUM PHENYLALANINE LEVELS AND MEAN PHENYLALANINE, PROTEIN, AND CALORIC 
INTAKE FOR PHENYLKETONURIC CHILDREN OF VARYING AGES*
MEAN PHENYLALANINE (mgs)
Intakes



















2.3 0.65 1.9 0.86 19.3 5.530 4 3 20.8 5.88 1.76 0.1.2 611 18212 53.6 1U.022? 71
li ? 6 5.1 0.69 2.6 2. [j.0 259 91 16.9 3.897 20.1* U.60 1.18 0.53 661* 11*5 1*1*. 7 6.1*
7 T 9 8.1 0.9U 2.8 2.20 288 5711 15.1* 3. hi* 25.1* 6.30 1.31* 0.28 856 11*8 1*5.8 6.8
10 Xl21* 11.0 1.15 1.1* 1.1*0 271 78 ll*.3 3.10 25.3 2.50 866 126 1*5.3 5.31.30 0.13
hO 13 X 36 
37 T 72 
73<~108
22.9 6.60 2.0 1.75 296 169 12.0 2.87 30.8 8.10 1.25 0.27
1.10y 0.26
1086 271* 1*3.9 9.1
1*2.5Z 6.938 51.1 8.53 1*05 161* 10.5^ 3.50 1*1.7^ 10.80 1569Z 312 
1817x 1*65
2.7 2.10
1*5.7X 12.109.7X 3.9187.0 6.52 2.5 1.90 0.95x 0.251*88 221*17 37.8X 8.9
*Data in this table are only for those children -who had serum phenylalanine levels less than or equal to 
six milligrams per cent at the time of the measure.
Note: w Age intervals in months
x N = 16
y N = 36




























4 < 6 7 < 9 10 < 120 < 3Age in Months
FIGURE 2
COMPARISON OF MEAN SERUM PHENYLALANINE, AND MEAN INTAKES OF 
PHENYLALANINE, PROTEIN, AND CALORIES FROM BIRTH THROUGH
12 MONTHS
49


































4 < 60 < 3 10 < 12Age in Months 7 < 9
FIGURE 3
COMPARISON OF MEAN SERUM PHENYLALANINE, AND MEAN INTAKES 
OF PHENYLALANINE, PROTEIN, AND CALORIES WITH NATIONAL 













































13 < 36 73 < 10837 < 72Age in Months
FIGURE 4
COMPARISON OF MEAN SERUM PHENYLALANINE, AND MEAN INTAKES OF 
PHENYLALANINEPROTEIN, AND CALORIES WITH NATIONAL RESEARCH 
COUNCIL RECOMMENDED ALLOWANCES FROM 13 THROUGH 108 MONTHS
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Mean phenylalanine intakesthan six milligrams per cent, 
were from 227 to 488 milligrams per day with standard
deviations of 57 to 224 milligrams. Phenylalanine 
Intakes based on the child*s weight ranged from 19.3 
milligrams per pound each day for Group 1, to a low of 
9.7 milligrams per body weight In Group 7* Standard 
deviations were greatest in the youngest group. Total 
daily phenylalanine Intake was greatest in the oldest 
children, but the youngest children had the highest 
intake when this intake was based on milligrams per pound 
of body weight.
The data for protein intake as grams of protein 
per day and as grams of protein per pound of body weight 
each day is given in Table II, Group 1 had a mean dally 
intake of 20.8 grams of proteinj Group 2, 20.4; Group 3, 
25.4; Group 4, 25.3j Group 5, 30.8; Group 6, 41.7; and 
Group 7, 45.7. Standard deviations ranged from 12,1 in 
the oldest age group to 2.5 In Group 4, however, this 
group had the smallest number of measures. When the 
protein intake was figured on the basis of grams per 
pound of body weight each day, a high of I.76 grams was 
observed in the youngest age group with a gradual
decrease to O.95 grams in the oldest age group.
Caloric Intake ranged from a high of 1817 calories 
each day for ages 73-108 months, to a low of 6ll for the 
infants as shown in Table II, page 47. Calories per
pound of body weight each day were in inverse order;
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the youngest consumed the greatest number per weight 
(53.6). Groups 2, 3, 4, 5, and 6 had intakes of 44.7, 
45.8, 45.3, 43.9, and 42.5 calories per pound, respect­
ively. The oldest group had an intake of 37.8 calories 
for each pound of weight, about 5 calories less than the 
group immediately preceeding. The standard deviation 
for calories in Group 1 was 14.0 calories per pound each 
day. This was in line with other reports in the liter­
ature that there were great differences between individ-
^ In theuals of the same age as to caloric consumption, 
older age groups, the standard deviations were not as
large; this too was in line with previous findings that 
there was less change in children from age one year 
until the pre-pubertal spurt than in the infant. Probably 
none of the children had reached this age, since the data 
Included only those up to nine years of age.
In Table III, the intake of phenylalanine per
pound of body weight daily was compared with the amounts 
recommended by Acosta.'*- The means for Groups 1, 2, and 
4 were below her recommended amounts, the means for
Groups 3 and 5 were within the recommended amounts, and 
the means for Groups 6 and 7 were slightly higher than 
those recommended. However, these two age groups obtained 
more protein from sources other than the casein hydrol­
ysate and the method of arriving at this nutrient data 
has been changed since July, 1965. If the more recent
TABLE III















Ref. 1 89 StudyN R CStudy N R C StudyN R CStudy N R C Study
52.3 53.61.1k 1.76 61120.8IjO - 200 £ 312 19.3
UU.7661; 52.320.U l.lli 1.18hZ 6 liO - 20 16.97
52.3 U5.885615.li 25.U 1.3U20 - 15 l.lli11 7 g 9 
10 £ 12 U5.352.3U 20 - 15 lU.3 25.3 l.lU 8661.30
13 Z 36 
37 Z 72
U3.9liO 15 » 10 1.25 108630.812.0 32 1300
1569z U2.536 10.5 UO Ul.7 160010-7 1.10
16 73 £108 7 - 5 52 37.8U5.7 0.95 18179.7 2100
z N = 37
* Data in this table are only for those children who had serum phenylalanine levels less than or equal 




method of calculation had been used throughout it is
possible that calculated phenylalanine intake might be
lower. The analytical data for phenylalanine content
is lower in some foods than originally calculated on
the basis that all protein contains five per cent of the
amino acid phenylalanine.
The comparison of protein Intake for the study
group with that recommended by the National Research 
84Council is shown in Table III. The protein intake in 
the youngest group was considerably higher than the 
recommended allowances. Prom the age of three months 
to one year the intake was higher, though by a fairly 
small margin. At the age of 13-36 months, the intake 
was slightly less, being 30.8 grams compared with 32 
grams recommended. Those in Group 6 had slightly more 
than the recommended Intakes and Group 7 consumed approxi­
mately six grams of protein less than recommended.
Calories per pound of body weight each day for 
Group 1 was above the National Research Council Recommended 
Allowances by a slight margin; for all other groups, 
calories were less than those recommended. Evidently 
then the phenylketonuric children did not follow the 
usual pattern of ingesting more calories than recommended
by the National Research Council as did the normal
19children in the studies of Burke 88and Rueda-Williamson.
This might be due to one of many factors. One factor to
55
be considered was the necessity for strict control of the 
diet which would militate against high food consumption 
because of less variety and less opportunity for con­
suming high caloric foods due to snacking. Another 
factor was that the diet averages of the study were 
based on recorded intakes, while those of other studies 
have been based on "recall" histories; there could very 
well be a difference in the end results due to the two
different methods of securing the data. These data are 
graphically presented in Figures 2, 3* and 4, pages 48, 
49, and 50. The nutritional data was selected for 
inclusion only if the simultaneous serum phenylalanine 
was equal to or less than 6 milligrams per cent.
CHAPTER V
SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS
Forty-eight children treated for phenylketonuria 
were selected for study to determine If the growth of 
the children was different from the growth of the normal 
child population. Since heredity plays such a large 
part in the stature of an individual, the parents* 
heights were compared with the adult white American.
The heights of both father and mother were above 
that of the adult white American, however, the difference 
was very small, being 0.15 and 0.32 Inches, respectively.
The mean of the last reported height for the 
treated phenylketonuric children compared with the 
expected mean height for norms showed that the children 
were 1.4 Inches shorter; when this difference was tested 
statistically for significance, the results showed that 
there was a probability of only 1:1,000 that the results 
could have occurred by chance. Thus, it was concluded 
that treated phenylketonuric children are shorter than 
normal children. It was also shown that degree of control 
(of serum phenylalanine level) and the time of beginning 
treatment had no influence on the last heights of the 
treated phenylketonuric children.
Phenylalanine intake varied with the children and
with the ages of the children. The intake based on body
57
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weight was at a maximum for the early age group, 
intake in the infant to three months of age was consid­
erably above the National Research Council Recommended 
Allowances, the intake of 3-12 and the 37-72 month old 
groups were only slightly above the recommendations, 
whereas in the ages of 13-38 and 73-108 months, protein 
Intake was somewhat lower than the recommendations.
Protein
Calorie intake was slightly higher than the recommenda­
tions only in the 1-3 month old group.
The following recommendations were made for
further research based on the results and limitations of
this study:
1. Definite protocol be established regarding 
techniques to be used in securing the anthropometric 
measures. Height and/or length should be taken in a 
specific manner with a fixed age at which to begin using 
standing height; clothing should not be a factor in the 
weight measure.
In addition to height and weight, stem length.2.
bicristal and bisacromial measures should be taken to
allow for the study of the body proportions of the phenyl­
ketonuria.
Evaluation of the physical status of siblings. 





The anthropometric measurements be taken at 
constant Increments of time and if at all possible, these 
to be taken on the birthdate, the half year date, etc.
Further effort be made to secure more complete
5.
6.
data in all areas.
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Data from forty-eight medical records of phenyl­
ketonuria children under treatment were investigated to 
determine if growth, as measured by stature, was normal; 
and to determine if the state of control or the age at 
beginning of treatment had an effect on growth. Mean 
intakes of phenylalanine, protein, and calories were 
obtained on the nutritional data only if the silumtaneous 
serum phenylalanine was equal to or less than 6 milligrams 
per cent. These means were grouped according to the age 
of the children into 7 groups (Ck3, ^£6, 7<9, 10<12, 13<36, 
37<J2, and 73<108 months).
The height at beginning of treatment and the last 
measured height was compared with established norms of the 
Brush Foundation Study. To determine whether the state of 
control or age of beginning treatment were factors in 
growth, the children were divided into groups according to 
(1) age dietary treatment was instituted (equal to or less 
than six months and over six months), and (2) state of 
control. "Good” control for this part of the study was 
having serum phenylalanine levels equal to or less than 
4 milligrams per cent 75 P@r cent of the time, and "poor" 
control, those having levels over 4 milligrams per cent 
75 per cent of the time.
The mean height of the parents compared favorably 
with the mean height for the white American male and 
female. At beginning of treatment the children were 
approximately half an inch shorter than estimated norms
ii
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but at their last measured height they were 1,40 inches 
shorter. When the last recorded heights of the phenyl- 
ketonuric children were analyzed considering time of 
beginning of treatment and state of control during 
treatment, there was no significant difference between 
the groups.
The mean phenylalanine intake ranged from 227 to 
488 milligrams each day. On a pound basis Group 1 con­
sumed 19.3 milligrams per pound, with a gradual decrease 
to a low of 9.7 milligrams per pound in the 73 to 108 
month age group. Protein intakes ranged from 20.8 grams 
a day for Group 1 to 45.7 grams each day for Group 7.
The protein intake of the youngest group was above that 
recommended by the National Research Council, Groups 2,
3, 4, and 6 intakes were only slightly above the recommen­
dations, Groups 5 and 7 had a somewhat lower intake than 
recommended. Mean caloric intake ranged from 6ll to 1817 
calories each day, increasing with increasing age.
Calorie intake in Group 1 was 53*6 calories per pound of 
body weight. This was slightly higher than the recommended 
allowances. All other groups had mean calorie intakes less 
thah those the National Research Council recommends.
It was concluded that treated phenylketonuric children 
are significantly shorter than established norms but that 
age at beginning of treatment and control during treatment 
had no influence on the last heights of the children.
iii
